The First Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
World Neurosurg. 2022 Sep;165:e393-e400. doi: 10.1016/j.wneu.2022.06.065. Epub 2022 Jun 22.
The safety and benefit of mechanical thrombectomy (MT) in the treatment of acute ischemic stroke (AIS) patients with M2 segment middle cerebral artery occlusions remain uncertain.
To investigate the benefit of mechanical thrombectomy for M2 occlusion compared with M1 occlusion in patients with AIS.
The PubMed, Embase, and Cochrane Library databases were searched from inception to April 2021 to identify relevant articles. The main results comprised 90-day functional independence (modified Rankin Score from 0-2), successful recanalization (thrombectomy in cerebral infarction [TICI] 2b/3), mortality, and rates of symptomatic intracerebral hemorrhage after using modern thrombectomy devices. Odds ratios (ORs) were generated for binary variants. ReviewManager 5.3 software was used.
Ultimately, a total of 14 trials were included, with 3454 participants enrolled. MT for M2 occlusion had a higher rate of 3-month functional independence than M1 occlusion, but the difference was nonsignificant (OR: 1.19, 95% confidence interval [CI]: 0.98 to 1.46). The TICI2b/3 scores (OR: 0.71, 95% CI: 0.58-0.88) in M2 occlusion were remarkably lower than those in M1. The mortality and symptomatic intracerebral hemorrhage rates were comparable between the 2 groups. When comparing M2 and M1 occlusions, we found that there was no significant difference between stent retriever and aspiration in the modified Rankin Score (0-2) after AIS, but aspiration exerted an eminently higher recanalization rate with regard to TICI2b/3 (OR: 0.77, 95% CI: 0.61-0.96).
Compared with M1 occlusion, patients with M2 occlusion treated by MT demonstrated similar clinical outcomes in this study. Moreover, there was no difference between stent retriever and aspiration in treating M2 occlusion in terms of functional independence at 90 days. However, aspiration exerted a conspicuously higher recanalization rate in M2 occlusion than in M1 occlusion.
机械取栓(MT)治疗大脑中动脉 M2 段闭塞的急性缺血性脑卒中(AIS)患者的安全性和获益尚不确定。
探讨机械取栓治疗大脑中动脉 M2 段闭塞与 M1 段闭塞相比对 AIS 患者的获益。
从建库至 2021 年 4 月,检索 PubMed、Embase 和 Cochrane Library 数据库,以确定相关文章。主要结果包括 90 天功能独立性(改良 Rankin 评分 0-2 分)、成功再通(血栓切除后脑梗死溶栓分级 [TICI] 2b/3)、死亡率和使用现代取栓装置后症状性颅内出血的发生率。二分类变量采用比值比(OR)。采用 ReviewManager 5.3 软件进行分析。
最终共纳入 14 项试验,共纳入 3454 名参与者。与 M1 段闭塞相比,M2 段闭塞的 MT 治疗 3 个月后的功能独立性更高,但差异无统计学意义(OR:1.19,95%置信区间 [CI]:0.98 至 1.46)。M2 段闭塞的 TICI2b/3 评分(OR:0.71,95%CI:0.58-0.88)明显低于 M1 段闭塞。两组死亡率和症状性颅内出血发生率相当。比较 M2 和 M1 闭塞时,我们发现支架取栓和抽吸在 AIS 后改良 Rankin 评分(0-2)方面无显著差异,但抽吸在 TICI2b/3 方面具有更高的再通率(OR:0.77,95%CI:0.61-0.96)。
与 M1 段闭塞相比,本研究中 MT 治疗的 M2 段闭塞患者的临床结局相似。此外,在 90 天功能独立性方面,支架取栓和抽吸治疗 M2 段闭塞无差异。然而,抽吸在 M2 段闭塞中的再通率明显高于 M1 段闭塞。